1. How many patients have been treated with the following drugs (for any disease) in the past 6 months:
a. Ampyra (dalfampridine)
b. Aubagio (teriflunomide)
c. Avonex (interferon beta-1a)
d. Betaferon (interferon beta-1b)
e. Brabio (glatiramer acetate)
f. Copaxone (glatiramer acetate)
g. Extavia (beta interferon-1b)
h. Gilenya (fingolimod)
i. Lemtrada (alemtuzumab)
j. Mavenclad (cladribine)
k. Mayzent (siponimod)
l. Ocrevus (ocrelizumab)
m. Plegridy (peginterferon beta-1a)
n. Rebif (beta interferon-1a)
o. Tecfidera (dimethyl fumarate)
p. Tysabri (natalizumab)
q. Vumerity (diroximel fumarate)
r. Zeposia (ozanimod)
2. How many patients have been treated in the past 6 months for the following types of multiple sclerosis:
a. Relapsing remitting MS (RRMS)
b. Secondary progressive MS (SPMS)
c. Primary progressive MS (PPMS)
d. Multiple Sclerosis – any type
